Drug utilization study and adverse drug reactions of oral anti diabetics among type 2 diabetes mellitus patients in tertiary care hospital

Authors

  • Sahana M. Mogali Department of Pharmacology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India
  • Aruna Bhushan Department of Pharmacology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India
  • Jagadishchandra S. Ratnakar Department of Pharmacology, Belagavi Institute of Medical Sciences, Belagavi, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20191103

Keywords:

Adverse drug reactions, Drug utilisation, Oral antidiabetic drugs

Abstract

Background: The aim was to evaluate the drug utilization pattern of oral antidiabetic drugs in type 2 diabetes mellitus outpatients and monitor adverse drug reactions (ADRs) associated with oral antidiabetic drugs.

Methods: A retrospective observational study was carried out by collecting the data of type 2 diabetes mellitus patients visiting outpatient department of noncommunicable disease clinic of a tertiary care hospital for a period of one year. The data of demographic, drug utilization pattern and adverse drug reactions of patients on oral antidiabetic drugs was collected and entered in a proforma.

Results: Total number of patients in this study were 39 out of which 21 (53.85%) patients were females and 18 (46.15%) patients were males. Majority of patients were in the age group 51-70 years (66.6%). Metformin was the most commonly prescribed drug 76.9% followed by Glibenclamide 17.9%. About 7.7% of patients who were taking oral antidiabetic drugs later switched over to insulin as their blood glucose levels were not controlled. Out of 18 (46.15%) patients, hypertension (38.5%) was the most common comorbid condition and a concomitant drug was prescribed was amlodipine 25.6%. Among all the adverse drug reactions observed, diarrhoea was the most common adverse drug reaction reported 76.9%.

Conclusions: Metformin was the most commonly used oral antidiabetic drug. Diarrhoea was the common adverse drug reaction reported.

References

Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Longo DL, et al. In: Alvin C Powers. Diabetes mellitus: diagnosis, classification, and pathophysiology. Harrison’s Principles of Internal Medicine. 19th ed. USA: McGraw Hill; 2017:2398-2407.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes care. 1998;21(9):1414-31.

Adhikari AK, Vidyasagar G, Rathore DS, Balaram G, Bhakti G. Drug utilization review of antidiabetic drugs in patients of a tertiary care hospital of India. Indian J Hosp Pharm. 2011;48(2):32-4.

Alex SM, Srelekshmi BS, Smitha S, Jiji KN, Menon AS, Uma Devi P. Drug utilization pattern of antidiabetic drugs among diabetic outpatients in tertiary care hospital. Asian J Pharm Clin Res. 2015;8(2):144-6.

Upadhyay DK, Palaian S, Ravi Shankar P, Mishra P, Sah AK. Prescribing pattern in diabetic outpatients in tertiary care teaching hospital in Nepal. J Clin Diagn Res. 2007;3:248-55.

Vengurlekar S, Shukla P, Patidar P, Bafaa R, Jain S. Prescribing pattern of antidiabetic drugs in Indore city hospital. Indian J Pharm Sci. 2008;70(5):637-40.

Dare DJ, Dikshit RK, Gandhi AM. Utilization of some newer oral antidiabetic agents in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2012;2(2):146-51.

Kannan, Arshad, Kumar S. A study on drug utilization of oral hypoglycemic agents in type-2 diabetic patients. Asian J Pharm Clin Res. 2011;4:60-4.

Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type 2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2013;2:485-91.

Sivasankari V, Manivannan E, Priyadarsini SP. Drug utilization pattern of anti-diabetic drugs in a rural area of Tamil Nadu, South India - A prospective, observational study. Int J Pharm Bio Sci. 2013;4:514-9.

Agarwal R, Rath B, Saha K, Mohaptra S. Drug utilization pattern of antidiabetic agents in a tertiary care hospital of western Odisha, India. Int J Basic Clin Pharmacol. 2016;5(5):2222-6.

Thiyagu R, Arulmani R, Narmadha T, Ramlakshami S, Siraj ST. Drug Use Pattern Study of Antidiabetics in Outpatient Setting of a Secondary Care Hospital. Indian J Hosp Pharm. 2008;45(6):176-9.

Jenny L, Arifulla M, Sreedharan J, Muttappallymyalil J, Das R. Age and gender-based utilization pattern of antidiabetic drugs in Ajman, UAE. Malay J Pharm Sci. 2012;10(1):79-85.

John LJ, Arifulla M, Sreedharan J, Muttappallymyalil J, Das R, John J, et al. Age and gender-based utilization pattern of antidiabetic drugs in Ajman, United Arab Emirates. Malay J Pharm Sci. 2012;10:79-85.

Alam MS, Aqil M, Qadry SA, Kapur P, Pillai KK. Utilization pattern of oral hypoglycemic agents for diabetes mellitus type 2 patients attending out-patient department at a University hospital in New Delhi. Pharmacol Pharm. 2014;5:636-45.

Cheung CY, Tso AW, Cheung BM, Xu A, Ong KL, Law LS, et al. Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur J Endocrinol. 2011 Mar 1;164(3):381-8.

Okayasu S, Kitaichi K, Hori A, Suwa T, Horikawa Y, Yamamoto M et al. The evaluation of risk factors associated with adverse drug reactions by metformin in type 2 diabetes mellitus. Bio Pharm Bull 2012;35(6):933-7.

Downloads

Published

2019-03-23

How to Cite

Mogali, S. M., Bhushan, A., & Ratnakar, J. S. (2019). Drug utilization study and adverse drug reactions of oral anti diabetics among type 2 diabetes mellitus patients in tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 8(4), 700–703. https://doi.org/10.18203/2319-2003.ijbcp20191103

Issue

Section

Original Research Articles